3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
5
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Conditions
Lung Neoplasms
26
Carcinoma, Non-Small-Cell Lung
15
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Melanoma
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thoracic Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdomyosarcoma
1
Precancerous Conditions
1
Pneumonia
1
Pleural Effusion, Malignant
1
Interventions
pembrolizumab
7
Carboplatin
5
Cisplatin
4
Drug Therapy
3
Taxes
2
Specimen Handling
2
SS1(dsFv)PE38
2
Polymerase Chain Reaction
2
Paclitaxel
2
Oxaliplatin
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gene Expression Profiling
2
Fluorouracil
2
Doxorubicin
2
Cyclophosphamide
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
tocilizumab
1
tinostamustine
1
sodium thiosulfate
1
selinexor
1
rucaparib
1
olaparib
1
motexafin lutetium
1
liposomal doxorubicin
1
fludarabine
1
eribulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
X-Rays
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled